Site-specific integration by adeno-associated virus

Parvoviruses

Volumn , Issue , 2005, Pages 213-236

  Dutheil, Nathalie ^a   Linden, R Michael ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 35948962380     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (159)

1. Amiss, T. J., McCarty, D. M., Skulimowski, A. and Samulski, R. J. etal. 2003. Identification and characterization of an adeno-associated virus integration site in CV-1 cells from the African green monkey. Journal of Virology 77: 1904-15.
2. Bakowska, J. C., Di Maria, M. V., Camp, S. M. et al. 2003. Targeted transgene integration into transgenic mouse fibroblasts carrying the full-length human AAVS1 locus mediated by HSV/AAV rep(+) hybrid amplicon vector. Gene Therapy 10: 1691-702.
3. Balague, C., Kalla, M. and Zhang, W. W. 1997. Adeno-associated virus Rep78 protein and terminal repeats enhance integration of DNA sequences into the cellular genome. Journal of Virology 71: 3299-306.
4. Bantel-Schaal, U., 1995. Growth properties of a human melanoma cell line are altered by adeno-associated parvovirus type 2. International Journal of Cancer 60: 269-74.
5. Barton, P. J., Cullen, M. E., Townsend, P. J. et al. 1999. Close physical linkage of human troponin genes: organization, sequence and expression of the locus encoding cardiac troponin I and slow skeletal troponin T. Genomics 57: 102-9.
6. Batchu, R. B., Kotin, R. M.and Hermonat, P. L. 1994. The regulatory Rep protein of adeno-associated virus binds to sequences within the c-H-ras promoter. Cancer Letters 86: 23-31.
7. Batchu, R. B., Shammas, M. A., Wang, J. Y. and Munshi, N. C. 1999. Interaction of adeno-associated virus Rep78 with p53: implications in growth inhibition. Cancer Research 59: 3592-5.
8. Batchu, R. B., Shammas, M. A., Wang, J. Y. and Munshi, N. C. et al. 2001. Dual level inhibition of E2F-1 activity by adeno-associated virus Rep78. Journal of Biological Chemistry 276: 24315-22.
9. Beaton, A., Palumbo, P. and Berns, K. I. 1989. Expression from the adeno-associated virus p5 and p19 promoters is negatively regulated in trans by the Rep protein. Journal of Virology 63: 4450-4.
10. Bermingham, N., Hernandez, D., Balfour, A. et al. 1995. Mapping TNNC1: the gene that encodes cardiac troponin I in the human and the mouse. Genomics 30: 620-2.
11. Berns, K. I., Pinkerton, T. C., Thomas, G. F. and Hoggan, M. D. 1975. Detection of adeno-associated virus (AAV)-specific nucleotide sequences in DNA isolated from latently infected Detroit 6 cells. Virology 68: 556-60.
12. Bhavsar, P. K., Brand, N. J., Yacoub, M. H. and Barton, P. J. R. 1996. Isolation and characterization of the human cardiac troponin I gene (TNNI3). Genomics 35: 11-23.
13. Blake, M. C., Jambou, R. C., Swick, A. G., Kahn, J. W. and Azizkhan, J. C. 1990. Transcriptional initiation is controlled by upstream GC-box interactions in a TATAA-less promoter. Molecular Cell Biology 10: 6632-41.
14. Blake, J. A., Eppig, J. T., Richardson, J. E. and Davisson, M. T. et al. 2000. The Mouse Genome Database (MGD): expanding genetic and genomic resources for the laboratory mouse. The Mouse Genome Database Group. NucleicAcids Research 28: 108-11.
15. Bonne, G., Carrier, L., Richard, P., Hainque, B. and Schwartz, K. 1998. Familial hypertrophic cardiomyopathy: from mutations to functional defects. Circulation Research 83: 580-93.
16. Cao, W., Mattagajasingh, S. N., Xu, H. et al. 2002. TIMAP, a novel CAAX box protein regulated by TGF-beta1 and expressed in endothelial cells. American Journal ofPhysiology and Cell Physiology 283: C327-37.
17. Cathomen, T., Collete, D. and Weitzman, M. D. et al. 2000. A chimeric protein containing the N terminus of the adeno-associated virus Rep protein recognizes its target site in an in vivo assay. Journal of Virology 74: 2372-82.
18. Cathomen, T., Stracker, T. H., Gilbert, L. B. and Weitzman, M. D. 2001. A genetic screen identifies a cellular regulator of adeno- associated virus. Proceedings of NationalAcademy of Sciences USA 98: 14991-6.
19. Chadeuf, G., Favre, D., Tessier, J. et al. 2000. Efficient recombinant adeno-associated virus production by a stable rep-cap HeLa cell line correlates with adenovirus-induced amplification of the integrated rep-cap genome. Journal of Gene Medicine 2: 260-8.
20. Cheung, A. K., Hoggan, M. D., Hauswirth, W. W. and Berns, K. 1.1980. Integration of the adeno-associated virus genome into cellular DNA in latently infected human Detroit 6 cells. Journal of Virology33: 739-48.
21. Chiorini, J. A., Yang, L., Safer, B. and Kotin, R. M. 1995. Determination of adeno-associated virus Rep68 and Rep78 binding sites by random sequence oligonucleotide selection. Journal of Virology 69: 7334-8.
22. Chiorini, J. A., Zimmermann, B., Yang, L. et al. 1998. Inhibition of PrKX, a novel protein kinase and the cyclic AMP-dependent protein kinase PKA by the regulatory proteins of adeno-associated virus type 2. Molecular Cell Biology 18: 5921-9.
23. Clark, K. R., Voulgaropoulou, F. and Johnson, P. R. 1996. A stable cell line carrying adenovirus-inducible rep and cap genes allows for infectivity titration of adeno-associated virus vectors. Gene Therapy 3: 1124-32.
24. Cohen, P. T. 2002. Protein phosphatase 1-targeted in many directions. Journal of Cell Science 115: 241-56.
25. Costello, E., Saudan, P., Winocour, E., Pizer, L. and Beard, P. 1997. High mobility group chromosomal protein 1 binds to the adeno- associated virus replication protein (Rep) and promotes Rep- mediated site-specific cleavage of DNA, ATPase activity and transcriptional repression. Embo Journal 16: 5943-54.
26. Di Pasquale, G. and Stacey, S. N. 1998. Adeno-associated virus Rep78 protein interacts with protein kinase A and its homolog PRKX and inhibits CREB-dependent transcriptional activation. Journal of Virology 72: 7916-25.
27. Duan, D., Fisher, K. J., Burda, J. F. and Engelhardt, J. F. 1997. Structural and functional heterogeneity of integrated recombinant AAV genomes. Virus Research 48: 41-56.
28. Dutheil, N., Shi, F., Dupressoir, T. and Linden, R. M. 2000. Adeno- associated virus site-specifically integrates into a muscle- specific DNA region. Proceedings of National Academy of Sciences USA 97: 4862-6.
29. Dutheil, N., Yoon-Robarts, M., Ward, P. etal. 2004. Characterization of the mouse adeno-associated virus AAVS1 ortholog. Journal ofVirology 78: 8917-21.
30. Dyall, J. and Berns, K. I. 1998. Site-specific integration of adeno- associated virus into an episome with the target locus via a deletion-substitution mechanism. Journal ofVirology 72: 6195-8.
31. Dyall, J., Szabo, P. and Berns, K. I. 1999. Adeno-associated virus (AAV) site-specific integration: formation of AAV-AAVS1 junctions in an in vitro system. Proceedings of National Academy of Sciences USA 96: 12849-54.
32. Farah, C. S. and Reinach, F. C. 1995. The troponin complex and regulation of muscle contraction. Faseb Journal 9: 755-67.
33. Felsenfeld, G., Boyes, J., Chung, J., Clark, D. and Studitsky, V. 1996. Chromatin structure and gene expression. Proceedings of National Academy of Sciences USA 93: 9384-8.
34. Friedman-Einat, M., Grossman, Z., Mileguir, F. et al. 1997. Detection of adeno-associated virus type 2 sequences in the human genital tract. Journal of Clinical Microbiology 35: 71-8.
35. Fujioka, M., Takahashi, N., Odai, H. et al. 1998. A new isoform of human myosin phosphatase targeting/regulatory subunit (MYPT2): cDNA cloning, tissue expression and chromosomal mapping. Genomics 49: 59-68.
36. Gahlmann, R., Troutt, A. B., Wade, R. P., Gunning, P. and Kedes, L. 1987. Alternative splicing generates variants in important functional domains of human slow skeletal troponin T. Journal ofBiological Chemistry 262: 16122-6.
37. Giraud, C., Winocour, E. and Berns, K. I. 1994. Site-specific integration by adeno-associated virus is directed by a cellular DNA sequence. Proceedings of National Academy of Sciences USA 91: 10039-43.
38. Giraud, C., Winocour, E. and Berns, K. I. 1995. Recombinant junctions formed by site-specific integration of adeno-associated virus into an episome. Journal ofVirology 69: 6917-24.
39. Goodman, S., Xiao, X., Donahue, R. E. et al. 1994. Recombinant adeno- associated virus-mediated gene transfer into hematopoietic progenitor cells. Blood 84: 1492-500.
40. Gottlieb, J. and Muzyczka, N. 1988. In vitro excision of adeno- associated virus DNA from recombinant plasmids: isolation of an enzyme fraction from HeLa cells that cleaves DNA at poly(G) sequences. Molecular Cell Biology 8: 2513-22.
41. Grimwood, J., Gordon, L. A., Olsen, A. et al. 2004. The DNA sequence and biology of human chromosome 19. Nature 428: 529-35.
42. Grossman, Z., Mendelson, E., Brok-Simoni, F. et al. 1992. Detection of adeno-associated virus type 2 in human peripheral blood cells. Journal of General Virology 73: 961-6.
43. Han, L., Parmley, T. H., Keith, S. et al. 1996. High prevalence of adeno- associated virus (AAV) type 2 rep DNA in cervical materials: AAV may be sexually transmitted. Virus Genes 12: 47-52.
44. Handa, H., Shiroki, K. and Shimojo, H. 1977. Establishment and characterization of KB cell lines latently infected with adeno- associated virus type 1. Virology 82: 84-92.
45. Heister, T., Heid, I., Ackermann, M. and Fraefel, C. 2002. Herpes simplex virus type 1/adeno-associated virus hybrid vectors mediate site-specific integration at the adeno-associated virus pre-integration site, AAVS1: on human chromosome 19. Journal ofVirology 76: 7163-73.
46. Hermonat, P. L. 1991. Inhibition of H-ras expression by the adeno- associated virus Rep78 transformation suppressor gene product. Cancer Research 51: 3373-7.
47. Hermonat, P. L. 1994. Down-regulation of the human c-fos and c-myc proto-oncogene promoters by adeno-associated virus Rep78. Cancer Letters 81: 129-36.
48. Hermonat, P. L. and Batchu, R. B. 1997. The adeno-associated virus Rep78 major regulatory protein forms multimeric complexes and the domain for this activity is contained within the carboxy-half of the molecule. FEBS Letters 401: 180-4.
49. Hermonat, P. L., Santin, A. D., Batchu, R. B. and Zhan, D. 1998. The adeno-associated virus Rep78 major regulatory protein binds the cellular TATA-binding protein in vitro and in vivo. Virology 245: 120-7.
50. Hickman, A. B., Ronning, D. R., Kotin, R. M. and Dyda, F. 2002. Structural unity among viral origin binding proteins: crystal structure of the nuclease domain of adeno-associated virus Rep. Moleclar Cell 10: 327-37.
51. Hickman, A. B., Ronning, D. R., Perez, Z. N., Kotin, R. M. and Dyda, F. 2004. The nuclease domain of adeno-associated virus rep coordinates replication initiation using two distinct DNA recognition interfaces. Moleclar Cell 13: 403-14.
52. Hoggan, M. D., Thomas, G. F., Thomas, F. B. and Fohnson, F. B. 1972. Continuous 'carriage' of adenovirus associated virus genome in cell cultures in the absence of helper adenoviruses. In: Proceedings of the Fourth Lepetite Colloquium. Cocoyac, Mexico. Amsterdam: Elsevier-North Holland, p. 243.
53. Horer, M., Weger, S., Butz, K. et al. 1995. Mutational analysis of adeno-associated virus Rep protein-mediated inhibition of heterologous and homologous promoters. Journal ofVirology 69: 5485-96.
54. Huang, X., Pi, Y., Lee, K. J. et al. 1999. Cardiac troponin I gene knockout: a mouse model of myocardial troponin I deficiency. Circulation Research 84: 1-8.
55. Hunkeler, N. M., Kullman, J. and Murphy, A. M. 1991. Troponin I isoform expression in human heart. Circulation Research 69: 1409-14.
56. Huser, D. and Heilbronn, R. 2003. Adeno-associated virus integrates site-specifically into human chromosome 19 in either orientation and with equal kinetics and frequency. Journal of General Virology 84: 133-7.
57. Huser, D., Weger, S. and Heilbronn, R. 2002. Kinetics and frequency of adeno-associated virus site-specific integration into human chromosome 19 monitored by quantitative real-time PCR. Journal ofVirology 76: 7554-9.
58. Huser, D., Weger, S. and Heilbronn, R. et al. 2003. Packaging of human chromosome 19-specific adeno-associated virus (AAV) integration sites in AAV virions during AAV wild-type and recombinant AAV vector production. Journal ofVirology 77: 4881-7.
59. Huttner, N. A., Girod, A., Schnittger, S. et al. 2003. Analysis of site- specific transgene integration following cotransduction with recombinant adeno-associated virus and a rep encoding plasmid. Journal of Gene Medicine 5: 120-9.
60. Im, D. S. and Muzyczka, N. 1990. The AAV origin binding protein Rep68 is an ATP-dependent site-specific endonuclease with DNA helicase activity. Cell 61: 447-57.
61. Ito, M., Nakano, T., Erdodi, F. and Hartshorne, D. J. 2004. Myosin phosphatase: structure, regulation and function. Molecular Cell Biochemistry 259: 197-209.
62. James, J., Zhang, Y., Osinska, H. et al. 2000. Transgenic modeling of a cardiac troponin I mutation linked to familial hypertrophic cardiomyopathy. Circulation Research 87: 805-11.
63. James, J. A., Escalante, C. R., Yoon-Robarts, M. etal. 2003. Crystal structure of the SF3 helicase from adeno-associated virus type 2. Structure (Camb) 11: 1025-35.
64. James, J. A., Aggarwal, A. K., Linden, R. M. and Escalante, C. R. 2004. Structure of adeno-associated virus type 2 Rep40-ADP complex: Insight into nucleotide recognition and catalysis by superfamily 3 helicases. Proceedings of NationalAcademy of Sciences USA 101: 12455-60.
65. Jin, J. P., Brotto, M. A., Hossain, M. M. et al. 2003. Truncation by Glu180 nonsense mutation results in complete loss of slow skeletal muscle troponin T in a lethal nemaline myopathy. Journal of Biological Chemistry 278: 26159-65.
66. Johnston, J. J., Kelley, R. I., Crawford, T. O. et al. 2000. A novel nemaline myopathy in the Amish caused by a mutation in troponin T1. American Journal ofHuman Genetics 67: 814-21.
67. Kearns, W. G., Afione, S. A., Fulmer, S. B. et al. 1996. Recombinant adeno-associated virus (AAV-CFTR) vectors do not integrate in a site-specific fashion in an immortalized epithelial cell line. Gene Therapy 3: 748-55.
68. Kimura, A., Harada, H., Park, J. E. et al. 1997. Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy. Natural Genetics 16: 379-82.
69. Kokado, H., Shimizu, M., Yoshio, H. et al. 2000. Clinical features of hypertrophic cardiomyopathy caused by a Lys183 deletion mutation in the cardiac troponin I gene. Circulation 102: 663-9.
70. Kotin, R. M. 1994. Prospects for the use of adeno-associated virus as a vector for human gene therapy. Human Gene Therapy 5: 793-801.
71. Kotin, R. M. and Berns, K. I. 1989. Organization of adeno-associated virus DNA in latently infected Detroit 6 cells. Virology 170: 460-7.
72. Kotin, R. M., Siniscalco, M., Samulski, R. J. et al. 1990. Site-specific integration by adeno-associated virus. Proceedings of National Academy of Sciences USA 87: 2211-15.
73. Kotin, R. M., Menninger, J. C., Ward, D. C. and Berns, K. I. 1991. Mapping and direct visualization of a region-specific viral DNA integration site on chromosome 19q13-qter. Genomics 10: 831-4.
74. Kotin, R. M., Linden, R. M. and Berns, K. I. 1992. Characterization of a preferred site on human chromosome 19q for integration of adeno-associated virus DNA by non-homologous recombination. Embo Journal 11: 5071-8.
75. Kushwaha, S. S., Fallon, J. T. and Fuster, V. 1997. Restrictive cardiomyopathy. New England Journal of Medicine 336: 267-76.
76. Kyostio, S. R. and Owens, R. A. 1996. Identification of mutant adeno- associated virus Rep proteins which are dominant-negative for DNA helicase activity. Biochemical and Biophysical Research Communications 220: 294-9.
77. Kyostio, S. R., Owens, R. A., Weitzman, M. D. et al. 1994. Analysis of adeno-associated virus (AAV) wild-type and mutant Rep proteins for their abilities to negatively regulate AAV p5 and p19 mRNA levels. Journal of Virology 68: 2947-57.
78. Lamartina, S., Roscilli, G., Rinaudo, D., Delmastro, P. and Toniatti, C. 1998. Lipofection of purified adeno-associated virus Rep68 protein: toward a chromosome-targeting nonviral particle. Journal of Virology 72: 7653-8.
79. Lamartina, S., Ciliberto, G. and Toniatti, C. 2000a. Selective cleavage of AAVS1 substrates by the adeno-associated virus type 2 rep68 protein is dependent on topological and sequence constraints. Journal of Virology 74: 8831-42.
80. Lamartina, S., Sporeno, E., Fattori, E. and Toniatti, C. 2000. Characteristics of the adeno-associated virus pre-integration site in human chromosome 19: open chromatin conformation and transcription-competent environment. Journal of Virology 74: 7671-7.
81. Laughlin, C. A., Cardellichio, C. B. and Coon, H. C. 1986. Latent infection of KB cells with adeno-associated virus type 2. Journal of Virology 60: 515-24.
82. Linden, R. M., Ward, P., Winocour, E. and Berns, K. I. 1996a. Site- specific integration by adeno-associated virus. Proceedings of National Academy of Sciences USA 93: 11288-94.
83. Linden, R. M., Winocour, E. and Berns, K. I. et al. 1996b. The recombination signals for adeno-associated virus site-specific integration. Proceedings of National Academy of Sciences USA 93: 7966-72.
84. McCarty, D. M., Pereira, D. J., Zolotukhin, I. et al. 1994. Identification of linear DNA sequences that specifically bind the adeno- associated virus Rep protein. Journal of Virology 68: 4988-97.
85. McLaughlin, S. K., Collis, P., Hermonat, P. L. and Muzyczka, N. 1988. Adeno-associated virus general transduction vectors: analysis of proviral structures. Journal ofVirology 62: 1963-73.
86. Mayor, H. D., Drake, S., Stahmann, J. and Mumford, D. M. 1976. Antibodies to adeno-associated satellite virus and herpes simplex in sera from cancer patients and normal adults. American Journal ofObstetrics and Gynecology 126: 100-4.
87. Mehrle, S., Rohde, V. and Schlehofer, J. R. 2004. Evidence of chromosomal integration of AAV DNA in human testis tissue. Virus Genes 28: 61-9.
88. Meneses, P., Berns, K. I. and Winocour, E. 2000. DNA sequence motifs which direct adeno-associated virus site-specific integration in a model system. Journal ofVirology 74: 6213-6.
89. Miller, D. G., Rutledge, E. A. and Russell, D. W. 2002. Chromosomal effects of adeno-associated virus vector integration. Natural Genetics 30: 147-8.
90. Mogensen, J., Kruse, T. A. and Borglum, A. D. 1997. Assignment of the human cardiac troponin I gene (TNNI3 to chromosome 19q13.4 by radiation hybrid mapping. Cytogenetics and Cell Genetics 79: 272-3.
91. Mogensen, J., Kubo, T., Duque, M. et al. 2003. Idiopathic restrictive cardiomyopathy is part of the clinical expression of cardiac troponin I mutations. Journal ofClinical Investigation 111: 209-16.
92. Morner, S., Richard, P., Kazzam, E. et al. 2000. Deletion in the cardiac troponin I gene in a family from northern Sweden with hypertrophic cardiomyopathy, J Molecular Cell Cardiol, 32: 521-5.
93. Murphy, R. T., Mogensen, J., Shaw, A. et al. 2004. Novel mutation in cardiac troponin I in recessive idiopathic dilated cardiomyopathy. Lancet 363: 371-2.
94. Nony, P., Tessier, J., Chadeuf, G. et al. 2001. Novel cis-acting replication element in the adeno-associated virus type 2 genome is involved in amplification of integrated rep-cap sequences. Journal ofVirology 75: 9991-4.
95. Oelze, I., Rittner, K. and Sczakiel, G. 1994. Adeno-associated virus type 2 repgene-mediated inhibition of basal gene expression of human immunodeficiency virus type 1 involves its negative regulatory functions. Journal ofVirology 68: 1229-33.
96. Offenhauser, N., Borgonovo, A., Disanza, A. et al. 2004. The eps8 family of proteins links growth factor stimulation to actin reorganization generating functional redundancy in the Ras/Rac pathway. Molecular Biology Cell 15: 91-8.
97. Ogata, T., Kozuka, T. and Kanda, T. 2003. Identification of an insulator in AAVS1: a preferred region for integration of adeno-associated virus DNA. Journal of Virology 77: 9000-7.
98. Palombo, F., Monciotti, A., Recchia, A. etal. 1998. Site-specific integration in mammalian cells mediated by a new hybrid baculovirus-adeno-associated virus vector. Journal of Virology 72: 5025-34.
99. Pereira, D. J. and Muzyczka, N. 1997. The cellular transcription factor SP1 and an unknown cellular protein are required to mediate Rep protein activation of the adeno-associated virus p19 promoter. Journal of Virology 71: 1747-56.
100. Perry, S.V. 1998. Troponin T: genetics, properties and function. Journal ofMuscle Research and Cell Motility 19: 575-602.
101. Perry, S.V. 1999. Troponin I: inhibitor or facilitator. Molecular Cell Biochemistry 190: 9-32.
102. Philpott, N. J., Giraud-Wali, C., Dupuis, C. et al. 2002a. Efficient integration of recombinant adeno-associated virus DNA vectors requires a p5-rep sequence in cis. Journal of Virology 76: 5411-21.
103. Philpott, N. J., Gomos, J., Berns, K. I. and Falck-Pedersen, E. 2002. A p5 integration efficiency element mediates Rep-dependent integration into AAVS1 at chromosome 19. Proceedings of NationalAcademy of Sciences USA 99: 12381-5.
104. Pieroni, L., Fipaldini, C., Monciotti, A. et al. 1998. Targeted integration of adeno-associated virus-derived plasmids in transfected human cells. Virology 249: 249-59.
105. Ponnazhagan, S., Erikson, D., Kearns, W. G. et al. 1997. Lack of site- specific integration of the recombinant adeno-associated virus 2 genomes in human cells. Human Gene Therapy 8: 275-84.
106. Prasad, C. K., Meyers, C., Zhan, D. J. et al. 2003. The adeno-associated virus major regulatory protein Rep78-c-Jun-DNA motif complex modulates AP-1 activity. Virology 314: 423-31.
107. Recchia, A., Parks, R. J., Lamartina, S. et al. 1999. Site-specific integration mediated by a hybrid adenovirus/adeno-associated virus vector. Proceedings of National Academy of Sciences USA 96: 2615-20.
108. Rinaudo, D., Lamartina, S., Roscilli, G., Ciliberto, G. and Toniatti, C. 2000. Conditional site-specific integration into human chromosome 19 by using a ligand-dependent chimeric adeno-associated virus/Rep protein. Journal ofVirology 74: 281-94.
109. Rittner, K., Heilbronn, R., Kleinschmidt, J. A. and Sczakiel, G. 1992. Adeno-associated virus type 2-mediated inhibition of human immunodeficiency virus type 1 (HIV-1) replication: involvement of p78rep/p68rep and the HIV-1 long terminal repeat. Journal of General Virology 73: 2977-81.
110. Rizzuto, G., Gorgoni, B., Cappelletti, M. et al. 1999. Development of animal models for adeno-associated virus site-specific integration. Journal ofVirology 73: 2517-26.
111. Rohde, V., Erles, K., Sattler, H. P. et al. 1999. Detection of adeno- associated virus in human semen: does viral infection play a role in the pathogenesis of male infertility? Fertility and Sterility 72: 814-6.
112. Rutledge, E. A. and Russell, D.W. 1997. Adeno-associated virus vector integration junctions. Journal ofVirology 71: 8429-36.
113. Samson, F., de Jong, P. J., Trask, B. J. et al. 1992. Assignment of the human slow skeletal troponin T gene to, 19q13.4 using somatic cell hybrids and fluorescence in situ hybridization analysis. Genomics 13: 1374-5.
114. Samson, F., Mesnard, L., Mihovilovic, M. et al. 1994. A new human slow skeletal troponin T (TnTs) mRNA isoform derived from alternative splicing of a single gene. Biochemical and Biophysical Research Communications 199: 841-7.
115. Samulski, R. J., Berns, K. I., Tan, M. and Muzyczka, N. 1982. Cloning of adeno-associated virus into pBR322: rescue of intact virus from the recombinant plasmid in human cells. Proceedings of National Academy of Sciences USA 79: 2077-81.
116. Samulski, R. J., Srivastava, A., Berns, K. I. and Muzyczka, N. 1983. Rescue of adeno-associated virus from recombinant plasmids: gene correction within the terminal repeats of AAV. Cell 33: 135-43.
117. Samulski, R. J., Zhu, X., Xiao, X. et al. 1991. Targeted integration of adeno-associated virus (AAV) into human chromosome 19. Embo Journal 10: 3941-50.
118. Schmidt, M., Afione, S. and Kotin, R. M. 2000. Adeno-associated virus type 2 Rep78 induces apoptosis through caspase activation independently of p53. Journal ofVirology 74: 9441-50.
119. Shelling, A. N. and Smith, M.G. 1994. Targeted integration of transfected and infected adeno-associated virus vectors containing the neomycin resistance gene. Gene Therapy 1: 165-9.
120. Skinner, J. A. and Saltiel, A. R. 2001. Cloning and identification of MYPT3: a prenylatable myosin targetting subunit of protein phosphatase 1. Biochem Journal 356: 257-67.
121. Smith, D. H., Ward, P. and Linden, R. M. 1999. Comparative characterization of Rep proteins from the helper-dependent adeno-associated virus type 2 and the autonomous goose parvovirus. Journal ofVirology 73: 2930-7.
122. Smith, R. H. and Kotin, R. M. 2000. An adeno-associated virus (AAV) initiator protein, Rep78: catalyzes the cleavage and ligation of single-stranded AAV ori DNA. Journal ofVirology 74: 3122-9.
123. Smith, R. H., Spano, A. J. and Kotin, R. M. 1997. The Rep78 gene product of adeno-associated virus self-associates to form a hexameric complex in the presence of AAV ori sequences. Journal ofVirology 71: 4461-4471.
124. Song, S., Lu, Y., Choi, Y. K. et al. 2004. DNA-dependent PK inhibits adeno-associated virus DNA integration. Proceedings of National Academy of Sciences USA 101: 2112-16.
125. Surosky, R. T., Urabe, M., Godwin, S. G. et al. 1997. Adeno-associated virus Rep proteins target DNA sequences to a unique locus in the human genome. Journal ofVirology 71: 7951-9.
126. Takahashi, N., Ito, M., Tanaka, J. et al. 1997. Localization of the gene coding for myosin phosphatase, target subunit 1 (MYPT1) to human chromosome 12q15-q21. Genomics, 44: 150-2.
127. Tan, I., Ng, C. H., Lim, L. and Leung, T. 2001. Phosphorylation of a novel myosin binding subunit of protein phosphatase 1 reveals a conserved mechanism in the regulation of actin cytoskeleton. Journal of Biological Chemistry 276: 21209-16.
128. Tezak, Z., Nagaraju, K., Plotz, P. and Hoffman, E. P. 2000. Adeno- associated virus in normal and myositis human skeletal muscle. Neurology 55: 1913-7.
129. Tobiasch, E., Rabreau, M., Geletneky, K. et al. 1994. Detection of adeno-associated virus DNA in human genital tissue and in material from spontaneous abortion. Journal ofMedical Virology 44: 215-22.
130. Tocchetti, A., Confalonieri, S., Scita, G., Di Fiore, P. P. and Betsholtz, C. 2003. In silico analysis of the EPS8 gene family: genomic organization, expression profile and protein structure. Genomics 81: 234-44.
131. Towbin, J. A. 2000. Molecular genetics of hypertrophic cardiomyopathy. Current Cardiology Report 2: 134-40.
132. Towbin, J. A. and Bowles, N. E. 2001. Molecular genetics of left ventricular dysfunction. Current Molecular Medicine 1: 81-90.
133. Tsunoda, H., Hayakawa, T., Sakuragawa, N. and Koyama, H. 2000. Site- specific integration of adeno-associated virus-based plasmid vectors in lipofected HeLa cells. Virology 268: 391-401.
134. Tullis, G. E. and Shenk, T. 2000. Efficient replication of adeno- associated virus type 2 vectors: a c/s-acting element outside of the terminal repeats and a minimal size. Journal of Virology 74: 11511-21.
135. Ueno, T., Matsumura, H., Tanaka, K. etal. 2000. Site-specific integration of a transgene mediated by a hybrid adenovirus/adeno-associated virus vector using the Cre/loxP- expression-switching system. Biochemical and Biophysical Research Communications 273: 473-8.
136. Urabe, M., Hasumi, Y., Kume, A. et al. 1999. Charged-to-alanine scanning mutagenesis of the N-terminal half of adeno- associated virus type 2 Rep78 protein. Journal of Virology 73: 2682-93.
137. Urabe, M., Kogure, K., Kume, A. et al. 2003. Positive and negative effects of adeno-associated virus Rep on AAVS7-targeted integration. Journal of General Virology 84: 2127-32.
138. Urcelay, E., Ward, P., Wiener, S. M., Safer, B. and Kotin, R. M. 1995. Asymmetric replication in vitro from a human sequence element is dependent on adeno-associated virus Rep protein. Journal of Virology 69: 2038-46.
139. Walker, S. L., Wonderling, R. S. and Owens, R. A. 1997. Mutational analysis of the adeno-associated virus type 2 Rep68 protein helicase motifs. Journal ofVirology 71: 6996-7004.
140. Walz, C. and Schlehofer, J. R. 1992. Modification of some biological properties of HeLa cells containing adeno-associated virus DNA integrated into chromosome 17. Journal ofVirology 66: 2990-3002.
141. Wang, X. S. and Srivastava, A. 1997. A novel terminal resolution-like site in the adeno-associated virus type 2 genome. Journal of Virology 71: 1140-6.
142. Wang, Y., Camp, S. M., Niwano, M. et al. 2002. Herpes simplex virus type 1/adeno-associated virus rep(+) hybrid amplicon vector improves the stability of transgene expression in human cells by site-specific integration. Journal ofVirology 76: 7150-62.
143. Ward, P. and Berns, K. I. 1991. In vitro rescue of an integrated hybrid adeno-associated virus/simian virus 40 genome. Journal of Molecular Biology 218: 791-804.
144. Ward, P. and Linden, R. M. 2000. A role for single-stranded templates in cell-free adeno-associated virus DNA replication. Journal of Virology 74: 744-54.
145. Ward, P., Dean, F. B., O'Donnell, M. E. and Berns, K. I. 1998. Role of the adenovirus DNA-binding protein in in vitro adeno-associated virus DNA replication. Journal ofVirology 72: 420-7.
146. Ward, P., Falkenberg, M., Elias, P., Weitzman, M. and Linden, R. M. 2001. Rep-dependent initiation of adeno-associated virus type 2 DNA replication by a herpes simplex virus type 1 replication complex in a reconstituted system. Journal ofVirology 75: 10250-8.
147. Ward, P., Elias, P. and Linden, R. M. 2003. Rescue of the adeno- associated virus genome from a plasmid vector: evidence for rescue by replication. Journal ofVirology 77: 11480-90.
148. Weger, S., Hammer, E. and Heilbronn, R. 2002. Topors, a p53 and topoisomerase I binding protein, interacts with the adeno- associated virus (AAV2 Rep78/68 proteins and enhances AAV2 gene expression. Journal of General Virology 83: 511-16.
149. Weger, S., Wendland, M., Kleinschmidt, J. A. and Heilbronn, R. 1999. The adeno-associated virus type 2 regulatory proteins rep78 and rep68 interact with the transcriptional coactivator PC4. Journal ofVirology 73: 260-9.
150. Weitzman, M. D., Kyostio, S. R., Kotin, R. M. and Owens, R. A. 1994. Adeno-associated virus (AAV) Rep proteins mediate complex formation between AAV DNA and its integration site in human DNA. Proceedings of National Academy of Sciences USA 91: 5808-12.
151. Winocour, E., Puzis, L., Etkin, S. et al. 1992. Modulation of the cellular phenotype by integrated adeno-associated virus. Virology 190: 316-29.
152. Wonderling, R. S. and Owens, R. A. 1996. The Rep68 protein of adeno-associated virus type 2 stimulates expression of the platelet-derived growth factor B c-sis proto-oncogene. Journal ofVirology 70: 4783-6.
153. Wonderling, R. S. and Owens, R. A. 1997. Binding sites for adeno- associated virus Rep proteins within the human genome. Journal ofVirology 71: 2528-34.
154. Wonderling, R. S., Kyostio, S. R., Walker, S. L. and Owens, R. A. 1997. The Rep68 protein of adeno-associated virus type 2 increases RNA levels from the human cytomegalovirus major immediate early promoter. Virology 236: 167-76.
155. Yang, C. C., Xiao, X., Zhu, X. et al. 1997. Cellular recombination pathways and viral terminal repeat hairpin structures are sufficient for adeno-associated virus integration in vivo and in vitro. Journal ofVirology 71: 9231-47.
156. Yoon, M., Smith, D. H., Ward, P. et al. 2001. Amino-terminal domain exchange redirects origin-specific interactions of adeno-associated virus rep78 in vitro. Journal ofVirology 75: 3230-9.
157. Yoon-Robarts, M. and Linden, R. M. 2003. Identification of active site residues of the adeno-associated virus type 2 Rep endonuclease. Journal ofBiological Chemistry 278: 4912-8.
158. Young, S. M. Jr. and Samulski, R. J. 2001. Adeno-associated virus (AAV) site-specific recombination does not require a Rep- dependent origin of replication within the AAV terminal repeat. Proceedings of National Academy of Sciences USA 98: 13525-30.
159. Young, S. M. Jr., McCarty, D. M., Degtyareva, N. and Samulski, R. J. 2000. Roles of adeno-associated virus Rep protein and human chromosome 19 in site-specific recombination. Journal of Virology 74: 3953-66.